[VRTX] YoY Quarter Result on 30-Sep-2013 [#Q3]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
07-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- -117.13%
YoY- -115.71%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 413,783 309,816 178,987 221,700 336,006 659,200 23,795 60.88%
PBT -42,034 -92,486 -166,577 -129,406 -5,112 200,610 -208,957 -23.43%
Tax 503 1,330 3,419 -751 21,355 -27,842 3,477 -27.52%
NP -41,841 -95,149 -170,060 -124,125 -57,543 221,110 -208,957 -23.49%
Tax Rate - - - - - 13.88% - -
Total Cost 455,624 404,965 349,047 345,825 393,549 438,090 232,752 11.83%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin -10.11 -30.71 -95.01 -55.99 -17.13 33.54 -878.16 -52.44%
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
EPS -0.17 -0.39 -0.72 -0.54 -0.27 1.06 -1.04 -26.03%
EPS Diluted -0.17 -0.39 -0.72 -0.54 -0.27 1.02 -1.04 -26.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.